Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Lung Transplant Rejection: later-stage trial registry
5 of 7 indexed Lung Transplant Rejection trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #2,497 of 28,707 conditions by registered trial count.
7 US clinical trials · 5 currently recruiting · #2,497 of 28,707 conditions by registered trial count
Lung Transplant Rejection: 7 US clinical trials tracked, 5 recruiting.
Lung Transplant Rejection is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Zambon SpA, running 1 of these trials.
Enrollment posture brief
Registry condition lung-transplant-rejection
OPEN 5 | RECR 71% | LATE 2 | EARLY 1 | RANK #2497 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Advanced Endometrial Carcinoma (71% recruiting · 7 trials)
Lung Transplant Rejection lists 5 open slots (71% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Lung Transplant Rejection on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Lung Transplant Rejection is recruiting above its size-band peers.
5 of 7 indexed trials (71.4%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Lung Transplant Rejection trials is spread across many organizations.
Zambon SpA accounts for 1 of 7 trials (14.3%). 7 distinct sponsors appear on at least one study for this condition label.
-
Typical Lung Transplant Rejection enrolment sits around 169 participants.
Median target enrolment is 169 among the 7 trials that report a genuine target (sentinel values excluded). 1 of those (14.3%) plan for fewer than 100 participants.
-
Lung Transplant Rejection splits between interventional and observational designs.
4 interventional and 3 observational studies make up this index (57.1% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
7 total, page 1 of 1
Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes
Duke University
NCT06399302
Diagnostic and Therapeutic Applications of Microarrays in Lung Transplantation
University of Alberta
NCT02812290
A Study to Test How Effective Belumosudil Tablets Are for Treating Adult Participants With Chronic Lung Allograft Dysfunction
Sanofi
NCT06082037
Cryoprobe Biopsy and Chronic Rejection in Lung Transplant Recipients
Mayo Clinic
NCT06824402
Developing Hyperpolarized Gas MRI Signatures to Detect and Manage Acute Cellular Rejection
University of Virginia
NCT07046910
LAMBDA 002 (Lung Registry) Study
Natera
NCT05170425
Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Double Lung Transplant (BOSTON-2)
Zambon SpA
NCT03656926
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
| Phase 3 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Lung Transplant Rejection records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Lung Transplant Rejection trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Lung Transplant Rejection page
7 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 5 Lung Transplant Rejection trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Zambon SpA sponsors the most Lung Transplant Rejection trials on record, review their full trial history before evaluating a specific study. See Zambon SpA's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Lung Transplant Rejection condition card totals 7 registered trials; most-linked intervention Liposomal Cyclosporine A; top US site state Maryland. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.